Is there a clinical need for a diagnostic test allowing detection of chain type–specific anti‐A and anti‐B? (CME)

Abstract

An ELISA with structurally defined ABH antigens will allow the antibody class and fine specificity of ABO antibodies to be determined, which may improve risk assessment in ABO-incompatible transplantation.